Cabral Concept 2749 - Stephen Cabral

WW: New “Triple G” Weight Loss Drug Released

There are some new weight loss pharmaceuticals on the market that tout some great results…

I always strive to bring you an unbiased opinion so I want to make sure you are aware of the results some of these medications can achieve.

On the other hand, I think it is important for you to fully understand how these work in the body and what they could be doing to your metabolism if you are not careful, and I implore you to always seek out the underlying root cause first.

So on today’s #CabralConcept 2749, I want to share with you the research behind the release of the new “Triple G” weight loss drug and go over the pros and cons associated with it so you can decide what is best for you – Enjoy the show and let me know what you thought!

– – –

Subscribe On

Audio Podcast:

Video Podcast:

Show Highlights & Big Takeaways:

1. What are GLP-1 Medications

GLP-1 stands for Glucagon-like peptides, and they are a class of medications that were originally used to help those with type-2 diabetes but are now being used for weight loss.

2. What Makes Retatrutide a Triple G Weight Loss Drug

“The three hormones that the retatrutide molecule simultaneously mimics are glucagon-like peptide-1 (GLP-1), such as agents in the class of GLP-1 agonists that includes liraglutide (Victoza/Saxenda) and semaglutide (Ozempic/Wegovy); the glucose-dependent insulinotropic polypeptide (GIP), the receptor that is also activated by tirzepatide (Mounjaro), a dual-incretin receptor agonist that mimics both GLP-1 and GIP; and glucagon. Survodutide is a dual GLP-1 and glucagon receptor agonist in phase 2 development.” https://www.medscape.com/viewarticle/995316#?form=fpf

3. What Are the Side Effects of GLP-1 Medications

All GLP-1 medications have numerous side effects including nausea, vomiting, and diarrhea. The most recent medication, Retatrutide, has been shown to cause gastroparesis and cyclical vomiting. Additionally, many people experience significant muscle loss which can have substantial long-term effects on metabolism.